BPG is committed to discovery and dissemination of knowledge
Citation
Jiang YJ, Wu L, Yang X, Pu Y, Ning BJ, Peng N, Zhu XJ. Dermatitis bullosa caused by the immune checkpoint inhibitor camrelizumab: A case report. World J Clin Cases 2025; 13(8): 97677 [PMID: 40094109 DOI: 10.12998/wjcc.v13.i8.97677]
Please LOGIN to submit a new comment.